TrialJournal for immunotherapy of cancer2026

Androgen deprivation, androgen receptor-targeted vaccination, and nivolumab in patients with high-risk localized prostate cancer.

David Jarrard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.